The GLG Healthcare Practice provides access to a global network of more than 55,000 experts from across the entire healthcare industry including physicians, researchers, scientists, and healthcare industry executives.
The Healthcare Practice provides insight into issues affecting the pharmaceutical, biotechnology, medical device, and healthcare services sectors.
David ZiolkowskiCOO/CIO
DOCTOR'S MEDICAL CENTER-SAN PABLO ![]()
David Ziolkowski is COO/CIO of Doctors Medical Center in San Pablo, CA. He is responsible for all hospital operations, as well as all Hospital IT functions. Prior to that, Mr. Ziolkowski was Senior Vice President and Chief Information Officer at the Sampson Regional Medical Center in Clinton, NC. He...
Hany SalamaVice President, Commercial Operations
NEOSTRATA COMPANY, INC. ![]()
Hany Salama, ME, MBA, CPM, is the Vice President, Commercial Operations at The NeoStrata Company. He has global responsibilities for commercial planning, supply chain, and manufacturing operations for all clinical and marketed products. Mr. Salama is also responsible for all new commercial productlaunches...
Keith Berman, MPH, MBAConsultant
HEALTH RESEARCH ASSOCIATES ![]()
Keith Berman, MPH, MBA, founded Health Research Associates in 1996. HRA provides reimbursement consulting, business development and market research services to leading biopharmaceuticals, blood products and medical device manufacturers and suppliers. Previously, Mr. Berman worked for ten years in product...
Orthopaedic Surgeon
Hospital of the University of Pennsylvania - CC ![]()
Samir Mehta, MD, is an orthopaedic surgeon at the Hospital of the University of Pennsylvania. Previously, he was an Instructor at Harborview Medical Center and Orthopaedic Surgeon and Assistant Professor of Orthopaedic Surgery in the Division of Orthopaedic Trauma at the University of PennsylvaniaHealth...
System Director of Purchasing
HALLMARK HEALTH SYSTEM, INC. ![]()
Louis Rocco is the System Director of Purchasing at Hallmark Health System, in Massachusetts. He has over 25 years of experience in purchasing and has negotiation, analytical, reporting and communication skills in inventory, distribution, purchasing, mailroom, reimbursement and accounts payable background....
| Study Group Name | No. Members |
|---|---|
| Oncologists (US) | 2257 |
| Pharmacists (US) | 2079 |
| Obstetricians/Gynecologists | 1962 |
| Neurologists | 1866 |
| Pediatricians (US) | 1717 |
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
Novartis, Sleeping Giant Wakes-Up in China
November 6, 2009
Novartis to invest US$ 1 bn to build largest pharma R&D institute in China | www.pharmabiz.com
Novartis to grow its China presence, late.Novartis has a slow response to market opportunities.GlaxoSmithKline and other big pharma players are perhaps too large to compete in the world's changing markets.
Is GE Global Research Developing a Portable Solar-Powered Ultrasound Device?
November 6, 2009
GE Global Research bags US$ 1.2 mn NIH project for developing technology in prenatal care | www.pharmabiz.com
As the recipient of a new NIH grant, GE Healthcare should create and design new innovative features as a way to differentiate its products in the nascent point-of-care portable ultrasound marketplace. Reasons why GE Healthcare should pursue a risk-taking strategy, such as developing a portable solar-powered...
Potential impact of large clinical trial on Liquid based cytology market
November 5, 2009
Robert Boorstein, MD, PhD, Associate Professor, Pathology, NEW YORK UNIVERSITY (INC)
Alternative to Pap Test Does Not Appear to Be Better for Detecting Cervical Cancer | www.medcompare.com
The data confirms what has long been known. There has never been definitive evidence for a benefit for Liquid based cytology screening compared with conventional screening, especially when sample collection is standardized and the laboratory meets reasonable standards.Objectively, liquid based cytology...
FDA Publishes H1N1 Diagnostic Test Guidance
November 5, 2009
Ken Powell, President, Genesis Business Development, LLC
FDA Publishes Guidance Document for H1N1 Dx | www.genomeweb.com
The FDA published document designed to help diagnostic test manufactures develop H1N1 tests and data that would accompany a FDA application to market them. This follows on the recent issuance of CDC guidelines for H1N1 tests.
Genomic Health Posts a 41% Q3 Revenue Increase
November 5, 2009
Ken Powell, President, Genesis Business Development, LLC
Genomic Health Posts 41 Percent Revenue Increase for Q3 | www.genomeweb.com
Genomic Health (NASDAQ: GHDX) posted Q3 revenues that were 41% greater than Q3 08. Virtually all of the revenue out performance was due to sales of the company's Oncotype Dx molecular diagnostic test for breast cancer used in developing a therapeutic strategy and assessing risk of recurrence.
November 12, 2009 | Boston
Seminar: Issues in Using PFS when Evaluating Oncology Products with Thomas Fleming, PhD (Boston)November 13, 2009 | New York
Seminar: Issues in Using PFS when Evaluating Oncology Products with Thomas Fleming, PhD (New York)November 20, 2009 | New York
Seminar: Issues in Using PFS when Evaluating Oncology Products with Thomas Fleming, PhDDecember 1, 2009 | Boston
Seminar: Hot Topics from Upcoming American Society of Hematology Meeting (New York)December 2, 2009 | Boston
Seminar: Hot Topics from Upcoming American Society of Hematology Meeting (Boston)View All GLG Live Meetings in Healthcare
Teleconference: Will Benlysta be the Miracle Drug for Lupus? (10:00 AM EST / 15:00 GMT)
November 3, 2009
Teleconference: Who Will Win the Anti-Obesity Pill Race? (9:00 AM EST / 13:00 GMT)
October 28, 2009
Teleconference: Future of Gaucher Disease Therapies (11:00 AM EST / 15:00 GMT)
October 27, 2009
Webcast: How Will Oral Cladribine and FTY-720 Impact the Multiple Sclerosis Market?
October 7, 2009
Webcast: Personalized Medicine Panel (2:00 PM EDT / 11:00 AM PDT / 19:00 BST)
August 5, 2009
245 U.S.-based neurologists share their opinion of Tysabri for the treatment of multiple sclerosis.
Reactions from ten top medical oncologists, powered by the GLG Healthcare CouncilsSM, regarding data presented by Amgen and Bayer at the 34th European Society of Medical Oncology (ESMO) Congress in Berlin the week of September 21, 2009.
FDA Publishes H1N1 Diagnostic Test Guidance
November 5, 2009
Synta Drug for Metastatic Melanoma Not Dead Yet (?)
November 3, 2009
Pharma Outsourcing: Where Will it End?
November 3, 2009
Delcath Phase III trial for metastatic melanoma completes enrollment
November 3, 2009
Healthy if You're Wealthy: Ghana offers Choices
November 2, 2009
www.reuters.com
www.businesswire.com
Synta Pharmaceuticals Announces Updated Elesclomol SYMMETRYSM Data Presented at Melanoma XIII
www.outsourcing-pharma.com
www.genomeweb.com
www.pharmabiz.com
Novartis to invest US$ 1 bn to build largest pharma R&D institute in China